IndraLab

Statements

2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate luteolin-7-olate(1-) inhibits MAPK8. 1 / 1

| 1

➶

reach

"Luteolin inhibits JNK1 and p90RSK activities, but not JNK2 and ERK2 activities in vitro."

23551430

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate luteolin-7-olate(1-) inhibits MAPK8. 1 / 1

INDRA sources:

Databases

Reading